1. Home
  2. YRD vs EOLS Comparison

YRD vs EOLS Comparison

Compare YRD & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YRD
  • EOLS
  • Stock Information
  • Founded
  • YRD 2012
  • EOLS 2012
  • Country
  • YRD China
  • EOLS United States
  • Employees
  • YRD N/A
  • EOLS N/A
  • Industry
  • YRD Finance: Consumer Services
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • YRD Finance
  • EOLS Health Care
  • Exchange
  • YRD Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • YRD 532.3M
  • EOLS 493.5M
  • IPO Year
  • YRD 2015
  • EOLS 2018
  • Fundamental
  • Price
  • YRD $5.73
  • EOLS $7.66
  • Analyst Decision
  • YRD
  • EOLS Strong Buy
  • Analyst Count
  • YRD 0
  • EOLS 5
  • Target Price
  • YRD N/A
  • EOLS $21.25
  • AVG Volume (30 Days)
  • YRD 88.0K
  • EOLS 1.2M
  • Earning Date
  • YRD 08-21-2025
  • EOLS 11-05-2025
  • Dividend Yield
  • YRD 7.68%
  • EOLS N/A
  • EPS Growth
  • YRD N/A
  • EOLS N/A
  • EPS
  • YRD 2.07
  • EOLS N/A
  • Revenue
  • YRD $856,794,857.00
  • EOLS $277,941,000.00
  • Revenue This Year
  • YRD N/A
  • EOLS $14.01
  • Revenue Next Year
  • YRD N/A
  • EOLS $29.46
  • P/E Ratio
  • YRD $2.76
  • EOLS N/A
  • Revenue Growth
  • YRD 12.42
  • EOLS 17.15
  • 52 Week Low
  • YRD $4.37
  • EOLS $5.71
  • 52 Week High
  • YRD $9.20
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • YRD 41.97
  • EOLS 50.21
  • Support Level
  • YRD $5.71
  • EOLS $7.19
  • Resistance Level
  • YRD $6.35
  • EOLS $7.67
  • Average True Range (ATR)
  • YRD 0.18
  • EOLS 0.34
  • MACD
  • YRD -0.02
  • EOLS 0.13
  • Stochastic Oscillator
  • YRD 4.38
  • EOLS 79.29

About YRD Yiren Digital Ltd.

Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: